ASCO 2019 was more exciting and enlightening than ever for our team of experts. Many people enjoyed live demonstrations of our cutting-edge technology and have insightful discussions on how to fight cancer through Data-Driven Medicine.
Attendees thus discovered:
SOPHiA for Genomics, the platform of choice for streamlined and advanced genomic data analysis, interpretation and reporting in the context of clinical oncology (solid tumors and hematological malignancies).
SOPHiA for Radiomics, the smart solution that covers the complete medical images analytical workflow, helping healthcare professionals to better monitor disease evolution and treatment efficacy and to improve outcome prediction.
SOPHiA for Clinical Trials, that leverages our expertise in Genomics and Radiomics, connecting patients to the right clinical trials, to accelerate the development of new therapies.
ASCO 2019 was finally the opportunity to officially launch the SOPHiA Solid Tumor Plus Solution: the expertly designed application to accurately characterize the complex mutational landscape of the major solid tumors using combined DNA and RNA analysis.
We can’t wait to see you next year in Chicago.